Restoring Cell Membrane Fat Balance Protects Brain from Stroke Damage

Cerebral ischemia-reperfusion injury, commonly known as ischemic stroke, is a devastating condition where blood flow to the brain is temporarily interrupted and then restored, leading to further damage. This secondary injury involves complex cellular processes, including neuronal autophagy (a cell's self-eating process) and ferroptosis (a distinct form of iron-dependent cell death). Cardiolipin, a unique phospholipid found in the inner mitochondrial membrane, is crucial for mitochondrial function and cellular energy production. Dysregulation of cardiolipin homeostasis is implicated in various pathologies, but the precise role of restoring cardiolipin balance in mitigating stroke injury by influencing ATG5-mediated autophagy and ferroptosis remained unclear.

The study demonstrated that restoring cardiolipin homeostasis significantly reduced brain damage and improved neurological outcomes. Treated mice exhibited a remarkable 42% reduction in infarct volume compared to vehicle controls (p<0.001) and showed a 35% improvement in neurological deficit scores. The most critical finding was that the cardiolipin-modulating agent suppressed the expression of ATG5 (a key protein in autophagy) by 2.8-fold and subsequently reduced neuronal autophagy, leading to a 55% decrease in markers of ferroptosis, such as lipid peroxidation and iron accumulation, in the ischemic penumbra. This suppression directly correlated with preserved mitochondrial function, evidenced by a 2.1-fold increase in ATP production and 18% less mitochondrial swelling in treated neurons. Furthermore, protein levels of GPX4 (an anti-ferroptotic enzyme) were upregulated by 1.7-fold in the treatment group, reinforcing the anti-ferroptotic effect.